Clinical Trial Update: Analyzing the Composition of Tears to Identify Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial exploring tear composition as a biomarker approach for cancer detection, involving breast and ovarian cancer cohorts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Snippet

Sponsor: University of Arkansas | Conditions: Breast Cancer, Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED